Agree Realty logo

Agree Realty

ADC | NYSE
Chart Builder DCF Calculator
$69.35
-$0.02 (-0.03%)
At close: Nov 16, 2026, 4:00 PM ET
$69.41
+$0.06 (+0.09%)
After-hours: Nov 16, 2026, 4:22 PM ET
-0.03%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
54.7
Fundamentals Average
Market Sentiment Bullish
Moat Narrow
Sector Rank #64/401 (Top 16%)

Key Statistics

Market Data

Market Cap $9.02B
1D Range
69.15 70.22
52W Range
64.49 81.92

Valuation (TTM)

PE 35.75
PB 1.30
EV/EBITDA 19.49

Valuation (NTM)

Forward PE 35.76
Forward PEG 4.19
Price Target $76.00
Loading financial charts...

Profile

Agree Realty Corporation functions as a publicly traded Real Estate Investment Trust (REIT), concentrating its efforts on the acquisition and development of commercial properties. These assets are pri...

Industry REIT - Retail
Employees 90
IPO Date Apr 15, 1994
Fiscal Year January - December

Latest News

Mr. Market Just Gave Me A Huge Gift For De-Risking My Portfolio

18 hours ago · seekingalpha.com

Mr. Market Just Gave Me A Huge Gift For De-Risking My Portfolio
Akari Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Continued Progress Toward Clinical Development of Differentiated ADC Payload Platform

4 days ago · globenewswire.com

Akari Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Continued Progress Toward Clinical Development of Differentiated ADC Payload Platform
Realty Income Delivers 18% Alpha Over Agree Realty

4 days ago · seekingalpha.com

Realty Income Delivers 18% Alpha Over Agree Realty
3 Monthly Dividend Stocks That Could Help Pay Your Retirement Bills

8 days ago · 247wallst.com

3 Monthly Dividend Stocks That Could Help Pay Your Retirement Bills
ADC Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Updates

8 days ago · prnewswire.com

ADC Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Updates
ADC Therapeutics Reports Strong Lymphoma Responses, Plans Phase III Study

12 days ago · marketbeat.com

ADC Therapeutics Reports Strong Lymphoma Responses, Plans Phase III Study
4 Monthly Dividend Stocks That Could Pay You Like Clockwork in Retirement

12 days ago · 247wallst.com

4 Monthly Dividend Stocks That Could Pay You Like Clockwork in Retirement
Hard To Imagine A Retirement Portfolio Without These 2 Dividend Machines

13 days ago · seekingalpha.com

Hard To Imagine A Retirement Portfolio Without These 2 Dividend Machines
ADC Therapeutics Announces Abstracts at the 68th ASH Annual Meeting Highlighting Breadth of ZYNLONTA® Clinical Program

13 days ago · prnewswire.com

ADC Therapeutics Announces Abstracts at the 68th ASH Annual Meeting Highlighting Breadth of ZYNLONTA® Clinical Program
Realty Income Just Raised Its Dividend Again. Here Are 2 More Monthly Payers

14 days ago · 247wallst.com

Realty Income Just Raised Its Dividend Again. Here Are 2 More Monthly Payers

Earnings

Latest Earnings
Oct 20, 2026
EPS
$1.15
Beat +143.18%
REV
$213.88M
Beat +1.12%
Next Earnings
Feb 9, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
14
Consensus
Buy
Price Target
$76.00
Upside
+9.59%
Buy (9)
Hold (5)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.